IBDEI10C ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16388,2)
;;=^5019598
;;^UTILITY(U,$J,358.3,16389,0)
;;=R80.3^^61^772^93
;;^UTILITY(U,$J,358.3,16389,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16389,1,3,0)
;;=3^Proteinuria Bence Jones
;;^UTILITY(U,$J,358.3,16389,1,4,0)
;;=4^R80.3
;;^UTILITY(U,$J,358.3,16389,2)
;;=^13272
;;^UTILITY(U,$J,358.3,16390,0)
;;=R80.9^^61^772^98
;;^UTILITY(U,$J,358.3,16390,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16390,1,3,0)
;;=3^Proteinuria,Unspec
;;^UTILITY(U,$J,358.3,16390,1,4,0)
;;=4^R80.9
;;^UTILITY(U,$J,358.3,16390,2)
;;=^5019599
;;^UTILITY(U,$J,358.3,16391,0)
;;=Z87.442^^61^772^86
;;^UTILITY(U,$J,358.3,16391,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16391,1,3,0)
;;=3^Personal Hx of Urinary Calculi
;;^UTILITY(U,$J,358.3,16391,1,4,0)
;;=4^Z87.442
;;^UTILITY(U,$J,358.3,16391,2)
;;=^5063497
;;^UTILITY(U,$J,358.3,16392,0)
;;=N18.1^^61^772^15
;;^UTILITY(U,$J,358.3,16392,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16392,1,3,0)
;;=3^Chronic Kidney Disease,Stage 1
;;^UTILITY(U,$J,358.3,16392,1,4,0)
;;=4^N18.1
;;^UTILITY(U,$J,358.3,16392,2)
;;=^5015602
;;^UTILITY(U,$J,358.3,16393,0)
;;=N18.2^^61^772^16
;;^UTILITY(U,$J,358.3,16393,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16393,1,3,0)
;;=3^Chronic Kidney Disease,Stage 2
;;^UTILITY(U,$J,358.3,16393,1,4,0)
;;=4^N18.2
;;^UTILITY(U,$J,358.3,16393,2)
;;=^5015603
;;^UTILITY(U,$J,358.3,16394,0)
;;=N18.4^^61^772^20
;;^UTILITY(U,$J,358.3,16394,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16394,1,3,0)
;;=3^Chronic Kidney Disease,Stage 4
;;^UTILITY(U,$J,358.3,16394,1,4,0)
;;=4^N18.4
;;^UTILITY(U,$J,358.3,16394,2)
;;=^5015605
;;^UTILITY(U,$J,358.3,16395,0)
;;=N18.5^^61^772^21
;;^UTILITY(U,$J,358.3,16395,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16395,1,3,0)
;;=3^Chronic Kidney Disease,Stage 5
;;^UTILITY(U,$J,358.3,16395,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,16395,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,16396,0)
;;=Q61.3^^61^772^89
;;^UTILITY(U,$J,358.3,16396,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16396,1,3,0)
;;=3^Polycystic Kidney,Unspec
;;^UTILITY(U,$J,358.3,16396,1,4,0)
;;=4^Q61.3
;;^UTILITY(U,$J,358.3,16396,2)
;;=^5018797
;;^UTILITY(U,$J,358.3,16397,0)
;;=N20.1^^61^772^11
;;^UTILITY(U,$J,358.3,16397,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16397,1,3,0)
;;=3^Calculus Ureter
;;^UTILITY(U,$J,358.3,16397,1,4,0)
;;=4^N20.1
;;^UTILITY(U,$J,358.3,16397,2)
;;=^5015608
;;^UTILITY(U,$J,358.3,16398,0)
;;=N18.9^^61^772^22
;;^UTILITY(U,$J,358.3,16398,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16398,1,3,0)
;;=3^Chronic Kidney Failure,Unspec
;;^UTILITY(U,$J,358.3,16398,1,4,0)
;;=4^N18.9
;;^UTILITY(U,$J,358.3,16398,2)
;;=^332812
;;^UTILITY(U,$J,358.3,16399,0)
;;=N18.6^^61^772^32
;;^UTILITY(U,$J,358.3,16399,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16399,1,3,0)
;;=3^End Stage Renal Disease (ESRD)
;;^UTILITY(U,$J,358.3,16399,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,16399,2)
;;=^303986
;;^UTILITY(U,$J,358.3,16400,0)
;;=N52.9^^61^772^49
;;^UTILITY(U,$J,358.3,16400,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16400,1,3,0)
;;=3^Erectile Dysfunction,Unspec
;;^UTILITY(U,$J,358.3,16400,1,4,0)
;;=4^N52.9
;;^UTILITY(U,$J,358.3,16400,2)
;;=^5015763
;;^UTILITY(U,$J,358.3,16401,0)
;;=N32.81^^61^772^84
;;^UTILITY(U,$J,358.3,16401,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16401,1,3,0)
;;=3^Overactive Bladder
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10C 3804 printed Nov 22, 2024@17:09:28 Page 2
IBDEI10C ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16388,2)
+2 ;;=^5019598
+3 ;;^UTILITY(U,$J,358.3,16389,0)
+4 ;;=R80.3^^61^772^93
+5 ;;^UTILITY(U,$J,358.3,16389,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,16389,1,3,0)
+8 ;;=3^Proteinuria Bence Jones
+9 ;;^UTILITY(U,$J,358.3,16389,1,4,0)
+10 ;;=4^R80.3
+11 ;;^UTILITY(U,$J,358.3,16389,2)
+12 ;;=^13272
+13 ;;^UTILITY(U,$J,358.3,16390,0)
+14 ;;=R80.9^^61^772^98
+15 ;;^UTILITY(U,$J,358.3,16390,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,16390,1,3,0)
+18 ;;=3^Proteinuria,Unspec
+19 ;;^UTILITY(U,$J,358.3,16390,1,4,0)
+20 ;;=4^R80.9
+21 ;;^UTILITY(U,$J,358.3,16390,2)
+22 ;;=^5019599
+23 ;;^UTILITY(U,$J,358.3,16391,0)
+24 ;;=Z87.442^^61^772^86
+25 ;;^UTILITY(U,$J,358.3,16391,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,16391,1,3,0)
+28 ;;=3^Personal Hx of Urinary Calculi
+29 ;;^UTILITY(U,$J,358.3,16391,1,4,0)
+30 ;;=4^Z87.442
+31 ;;^UTILITY(U,$J,358.3,16391,2)
+32 ;;=^5063497
+33 ;;^UTILITY(U,$J,358.3,16392,0)
+34 ;;=N18.1^^61^772^15
+35 ;;^UTILITY(U,$J,358.3,16392,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,16392,1,3,0)
+38 ;;=3^Chronic Kidney Disease,Stage 1
+39 ;;^UTILITY(U,$J,358.3,16392,1,4,0)
+40 ;;=4^N18.1
+41 ;;^UTILITY(U,$J,358.3,16392,2)
+42 ;;=^5015602
+43 ;;^UTILITY(U,$J,358.3,16393,0)
+44 ;;=N18.2^^61^772^16
+45 ;;^UTILITY(U,$J,358.3,16393,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,16393,1,3,0)
+48 ;;=3^Chronic Kidney Disease,Stage 2
+49 ;;^UTILITY(U,$J,358.3,16393,1,4,0)
+50 ;;=4^N18.2
+51 ;;^UTILITY(U,$J,358.3,16393,2)
+52 ;;=^5015603
+53 ;;^UTILITY(U,$J,358.3,16394,0)
+54 ;;=N18.4^^61^772^20
+55 ;;^UTILITY(U,$J,358.3,16394,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,16394,1,3,0)
+58 ;;=3^Chronic Kidney Disease,Stage 4
+59 ;;^UTILITY(U,$J,358.3,16394,1,4,0)
+60 ;;=4^N18.4
+61 ;;^UTILITY(U,$J,358.3,16394,2)
+62 ;;=^5015605
+63 ;;^UTILITY(U,$J,358.3,16395,0)
+64 ;;=N18.5^^61^772^21
+65 ;;^UTILITY(U,$J,358.3,16395,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,16395,1,3,0)
+68 ;;=3^Chronic Kidney Disease,Stage 5
+69 ;;^UTILITY(U,$J,358.3,16395,1,4,0)
+70 ;;=4^N18.5
+71 ;;^UTILITY(U,$J,358.3,16395,2)
+72 ;;=^5015606
+73 ;;^UTILITY(U,$J,358.3,16396,0)
+74 ;;=Q61.3^^61^772^89
+75 ;;^UTILITY(U,$J,358.3,16396,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,16396,1,3,0)
+78 ;;=3^Polycystic Kidney,Unspec
+79 ;;^UTILITY(U,$J,358.3,16396,1,4,0)
+80 ;;=4^Q61.3
+81 ;;^UTILITY(U,$J,358.3,16396,2)
+82 ;;=^5018797
+83 ;;^UTILITY(U,$J,358.3,16397,0)
+84 ;;=N20.1^^61^772^11
+85 ;;^UTILITY(U,$J,358.3,16397,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,16397,1,3,0)
+88 ;;=3^Calculus Ureter
+89 ;;^UTILITY(U,$J,358.3,16397,1,4,0)
+90 ;;=4^N20.1
+91 ;;^UTILITY(U,$J,358.3,16397,2)
+92 ;;=^5015608
+93 ;;^UTILITY(U,$J,358.3,16398,0)
+94 ;;=N18.9^^61^772^22
+95 ;;^UTILITY(U,$J,358.3,16398,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,16398,1,3,0)
+98 ;;=3^Chronic Kidney Failure,Unspec
+99 ;;^UTILITY(U,$J,358.3,16398,1,4,0)
+100 ;;=4^N18.9
+101 ;;^UTILITY(U,$J,358.3,16398,2)
+102 ;;=^332812
+103 ;;^UTILITY(U,$J,358.3,16399,0)
+104 ;;=N18.6^^61^772^32
+105 ;;^UTILITY(U,$J,358.3,16399,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,16399,1,3,0)
+108 ;;=3^End Stage Renal Disease (ESRD)
+109 ;;^UTILITY(U,$J,358.3,16399,1,4,0)
+110 ;;=4^N18.6
+111 ;;^UTILITY(U,$J,358.3,16399,2)
+112 ;;=^303986
+113 ;;^UTILITY(U,$J,358.3,16400,0)
+114 ;;=N52.9^^61^772^49
+115 ;;^UTILITY(U,$J,358.3,16400,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,16400,1,3,0)
+118 ;;=3^Erectile Dysfunction,Unspec
+119 ;;^UTILITY(U,$J,358.3,16400,1,4,0)
+120 ;;=4^N52.9
+121 ;;^UTILITY(U,$J,358.3,16400,2)
+122 ;;=^5015763
+123 ;;^UTILITY(U,$J,358.3,16401,0)
+124 ;;=N32.81^^61^772^84
+125 ;;^UTILITY(U,$J,358.3,16401,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,16401,1,3,0)
+128 ;;=3^Overactive Bladder
